Clinical Study
RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution
Table 1
Patients characteristics (
).
| Characteristic | Number | % |
| Sex | | | Male | 29 | 55.4 | Female | 36 | 44.6 | Age (years) | | | Mean | 61.45 years | Range | 30–85 years | FLIPI | | | Good | 38 | 58.5 | Intermediate | 19 | 29.2 | Poor | 8 | 12.3 | ECOG | | | 1-2 | | 96.9 | Prior treatment | | | >2 | 26 | 4 |
|
|